ORIGINAL RESEARCH

Prediction of bacterial vulvovaginitis in girls at different Tanner stages of sexual development

About authors

1 Samara State Medical University, Samara, Russia

2 Kulakov Federal Research Center for Obstetrics, Gynecology, and Perinatolоgy, Moscow, Russia

Correspondence should be addressed: Anna V. Kazakova
Lesnaya 31, kv. 40, Samara, 443110; ur.xednay@08912041ogima

About paper

Author contribution: Kazakova AV — study concept and design, data acquisition and analysis, manuscript draft; Uvarova EV — study concept and design, manuscript revision; Limareva LV — study concept and design, manuscript revision; Trupakova AA, Mishina AI — data acquisition and analysis, manuscript draft.

Received: 2019-09-27 Accepted: 2019-10-17 Published online: 2019-10-29
|

In recent years, there have been reports of declining health statistics and the growing incidence of reproductive and gynecological disorders in children and adolescents [14]. Due to its high prevalence in children of all ages, genital inflammation is regarded as a clinically important problem [57]. Vulvovaginitis is the most common type of inflammatory genital conditions (84.2%) in girls under 10 years of age [810].
In young females, the main susceptibility factors include hormonal changes, lifestyle, poor intimate hygiene, and genetically determined features of immune response [1114]. Early age of sexual initiation is one of the factors disrupting reproductive health and provoking dysbiosis of vaginal microbiota [15]. A greater threat is posed by self-medication practices and delays in seeking medical advice.
Local immunity response affects the composition of vaginal microbiota and plays a leading role in driving inflammation [16]; however, the mechanisms maintaining immune tolerance remain understudied [17, 18].
Hygiene is an important aspect of sexual education. However, although hygiene practices are well-established and based on solid scientific evidence, hygiene habits differ across regions and among individuals with different social background. Unlike genetic factors that affect physical development and shape immune response, intimate hygiene and reproductive behavior can be modified to improve health. New approaches are needed to predict and prevent the risk of vulval and vaginal inflammation in young females.
The aim of this study was to develop a program for predicting the risk of vulval and vaginal inflammation in girls at different stages of sexual development. For that, we identified social, hygienic, clinical, and molecular-genetic prognostic markers of vulvovaginitis; proposed a prognostic model for predicting vulvovaginitis in girls; assessed the clinical effect of original prevention measures against vulval and vaginal inflammation in girls at different stages of sexual development.

METHODS

The study was conducted at the Outpatient Pediatric Department № 1 (Samara City Clinic № 13) from February 2013 to August 2016. The study recruited 252 healthy girls presenting for an annual check-up at the Clinic. All participants were stratified into a few groups according to their age. Age intervals reflected the stages of sexual development on the Tanner scale. Considering that the composition of vaginal microbiota in young girls is age-dependent, prognostic models were built for different sexual development stages: group 1 included 74 Tanner I girls and group 2, 178 Tanner II–V girls.
The following inclusion criteria were applied: age from 2 to 17 years, the absence of health complaints; no somatic or gynecological disorders; normal physical, psychological and sexual development.
Exclusion criteria were as follows: the use of antibacterial drugs in a month preceding the examination; acute inflammatory diseases at the time of examination and swab collection.
All girls and their mothers were interviewed using a questionnaire. Questions were asked about hygiene habits of mothers and their daughters and sexual behavior of the participants. Additionally, we studied 226 vaginal and 226 buccal swabs obtained from the girls.
Before the tests, complaints were taken, physical (height, weight, BMI) and sexual development (Tanner stage, external genital examination) was evaluated. Intimate hygiene practices were also assessed.

Swabs were collected from vaginal vestibule mucosa or the posterior fornix through hymenal rings using a standard swab kit. DNA of opportunistic microorganisms (OMs) was assayed in real-time PCR using a Femoflor-17 reagent kit (DNA-Technology; Russia) for profiling the composition of genitourinary microbiota. The following parameters were assessed: quality control of sample collection (SCQC); total bacterial mass (TBM); the presence of mollicutes (Mycoplasma hominis, Ureaplasma spp.), yeast (Candida spp.), bacteria (Lactobacillus spp., Enterobacterium spp., Streptococcus spp., Staphylococcus spp., Gardnerella vaginalis / Prevotella bivia / Porphyromonas spp., Eubacterium spp., Sneathia spp. / Leptotrichia spp. / Fusobacterium spp., Megasphaera spp. / Veillonella spp. / Dialister spp., Lachnobacterium spp. / Clostridium spp., Mobiluncus spp. / Corinebacterium spp., Peptostreptococcus spp., Atopobium vaginae), and pathogens (Mycoplasma genitalium). SCQC was valid in all cases, confirming the objectivity of the subsequent results analysis.

Considering the immune mechanisms underlying vulval and vaginal inflammation, we studied the distribution of allele and genotype frequencies for the following polymorphic variants of anti- and pro-inflammatory cytokine genes using PCR: IL1β (T-31C), IL1β (T-511C), IL1β(C-3953T), IL1β (G-1473C) in the IL1β gene; IL6 (C-174G) in the IL6 gene; TNFα (G-308A) in the TNFα gene; IL10 (G-1082A), IL10 (С-592А), IL10 (C-819T) in the IL10 gene; TGFβ1 (Arg25Pro) in the TGFβ1 gene in order to identify the role of polymorphisms of immune response genes in the development and clinical course of the pathology.
Decision trees were constructed using the classification and regression tree algorithm (CART). Briefly, each decision tree node had two children. In each step, the rule generated by the node split the dataset into two subsets: the one where the rule was satisfied and the other where it was not. The computer algorithm selected the attribute on which the node was split, determined the splitting value and decided when to stop tree bulding. The optimal rule was selected using the function for splitting quality assessment based on the Gini index [19].
The following groups of attributes were used to build our decision trees:
– information about vaginal microbiota obtained with the Femoflor kit (expressed as gram-equivalents and as percentage relative to TBM);
– results of molecular-genetic tests of polymorphic variants of genes coding for the selected cytokines;
– information about hygiene habits obtained from questionnaires (intimate washing, showering, changing underwear regularly, etc.).
Additionally, we calculated the ratio of lactobacilli (aerobes) to obligate anaerobes.

Testing the proposed recommendations on prevention

The obtained data were used to develop a set of prevention measures. To test their effect, we conducted a prospective study that enrolled 167 girls. The main group (n = 52) was given original recommendations proposed in this work; the control group (n = 115) received standard recommendations from a pediatric gynecologist. The girls were followed up for one year; then, the obtained data were statistically analyzed in compliance with the principles of evidence-based medicine [20].

Statistical analysis

The obtained data were saved to and processed in Microsoft Exсel. Statistical analysis was performed using the SPSS 21 software (IBM SPSS Statistics; USA, license 20130626-3). The applied methods of descriptive statistics included calculation of the arithmetic mean and its deviation (M ± m) or, in case of skewed distribution, the median and the quartile range. Information about the analyzed microorganisms was saved to a table; we specified the number of girls who had the identified species and the mean concentration of the microorganism expressed as a decadic logarithm (lg). Mean values were calculated only for the subgroup of girls who had the microorganism. For such variables as past infections, hygiene practices and genotypes, contingency tables were constructed and Pearson’s chi-squared was calculated.
The quality of classification was assessed using ROC-curves and evidence-based medicine criteria: sensitivity and specificity.

RESULTS

Considering that the composition of vaginal microbiota depends on age, we built models for predicting the risk of vulvovaginitis in 2 groups of girls at different Tanner stages: group 1 (Tanner 1) and group 2 (Tanner II–V).
The prognostic model for Tanner I girls is shown in fig. 1. The presence of the following two prognostic markers was considered a favorable risk factor: predominance of obligate anaerobes in the composition of vaginal microbiota and the polymorphic IL10 variant (С-819Т) homozygous for TT. If any of these two conditions was not satisfied or lactobacilli dominated the composition of vaginal microbiota or there was at least one C allele in the IL10 gene, this led to an increased risk of vulvovaginitis in girls from group 1.
The quality of prediction was assessed by constructing a contingency table for observed and predicted outcomes (tab. 1).
Nine predictions were false-positive (vulvovaginitis was predicted by the model but the girl turned out to be healthy). Three predictions were false-negative. In group 1, the sensitivity of the applied method was 80%, whereas specificity — 78%.
Based on the constructed decision tree, the prediction algorithm for Tanner I girls was as follows:
1. If the proportion of aerobes was > 34%, then the risk of vulvovaginitis was estimated as probable. If the proportion of aerobes was ≤ 34%, the algorithm proceeded to step 2.
2. If locus 819 of the IL10 gene was homozygous for the TT allele, then the risk of vulvovaginitis was considered minimal. If this locus was homozygous for the C allele (the CC genotype) or heterozygous (the CT genotype), then the risk of vulvovaginitis was estimated as high.

The prognostic model for predicting the risk of vulvovaginitis in Tanner II–V girls is shown in fig. 2. Favorable risk factors in prepubertal and pubertal girls included aerobic predominance in the composition of vaginal microbiota and the presence of the TT allele in the polymorphic IL10 gene variant (С-3953Т). If any of these two conditions was not satisfied (the smaller proportion of aerobes, the presence of at least one C allele in the IL10 gene), then an increased risk of vulvovaginitis in girls from group 2 was inferred. The sensitivity of the prognostic models was 58.3%, whereas specificity, 94.1%.
The prediction algorithm for Tanner II–V girls was as follows:
1. If the aerobic content expressed as genomic equivalents was ≤ 6.15, the algorithm proceeded to step 2. If the aerobic content expressed as genomic equivalents was > 6.15, the algorithm proceeded to step 4.
2. If the IL10 (С-592А) gene was homo- or heterozygous for at least one A allele, the risk of vulvovaginitis was estimated as minimal. If the polymorphic IL10 (С-592А) gene carried the CC genotype, the algorithm proceeded to step 3.
3. If a girl showered every day, she was at minimum risk for vulvovaginitis. If showering was not regular, the risk for vulvovaginitis was estimated as high.
4. If the IL1β (С-3953T) gene had the TT genotype, the risk for vulvovaginitis was minimal. If this gene had the CT or CC genotype, we proceeded to step 3.

It is known that a substitution of the T allele for the C allele at position -3953 in the IL1β gene results in a decreased production of proinflammatory IL1β and is clinically associated with a weaker immune response to an antigen. In combination with inadequate hygiene practices, this factor can be decisive in triggering inflammation.
When the A allele is substituted for the C allele at position -592 of the IL10 gene, the production of IL10 increases. IL10 is an anti-inflammatory cytokine; its overproduction during immune response to infection can undermine the effect of immune defense mechanisms. Although IL10 overproduction is determined genetically, the decision tree demonstrates that this factor exerts its negative impact only in case of poor hygiene practices.
Summing up, the use of decision trees allowed us to create a convenient and functional prognostic model for assessing the risk of vulvovaginitis and to analyze different allele combinations and their interplay.

Based on the reliable risk factors identified by our regression model, we proposed the following prevention measures for the girls over 16 years of age at risk for vulvovaginitis.
Tanner I girls were recommended 1) seeking medical advice with medical professionals immediately if genitourinary or ENT infections were noticed; 2) showering daily and changing underwear regularly; 3) washing the intimate area twice a day; 4) seeing a gynecologist once a year.
Tanner II–V girls were recommended 1) seeking medical advice with an allergist and regular check-ups in case of any allergies; 2) showering daily and changing underwear regularly; 3) washing the intimate area twice a day; 4) sexual initiation not earlier than 17 years; 5) safe sexual behavior: using reliable methods of contraception, sticking to one sex partner; 6) seeing a gynecologist once a year.

To assess the effect of our original prevention measures, we calculated the values for a number of quantitative indicators according to the recommendations by Kotelnikov GP and Shpigel AS [20]. A contingency table was constructed for additional prevention measures and relapses (tab. 2).
Study results are shown in tab. 3 and tab. 4. The 2 main indicators used to calculate the effect of prevention measures were relapse rates in the main (treatment) and control groups (RRM, RRC):

RRM = а / (a + b);

RRC = c / (c + d).

95% CI for RRM and RRC was calculated using the Wilson method.

RRM was 17.3% (95% CI: 9.4–29.7%); RRM, 34.8% (95% CI: 26.7–43.9%); р = 0.035 (Pearson’s χ2 was applied).
The difference between the relapse rates in the main and control groups was estimated using the values of relative and absolute risk reduction (RRR, ARR).
RRR represented the decrease in the relapse rate in the main group relative to the control group:

RRR = (RRC – RRM) / RRC.

ARR represented the difference between the relapse rates in the main and control groups:

ARR = RRC – RRM.

95% CI for RRR was calculated using the method proposed by M. Gardner and D. Altman; 95% CI for ARR was calculated using the method proposed by L. Bjerre and J. LeLorier [:lit_21, 22].
In this study, the relapse rate in the main group dropped by 17.5% (95% CI: 2.7–29.5%), i.e., twofold:

RRR = (34.8 – 17.3) / 34.8 × 100% = 50.2%.

OR for the relapse rate with CI calculated according to J. Bland and D. Altman, was 0.39 (95% CI: 0.17–0.89).
Subsequently, we calculated the number of patients (NP) who had to follow the proposed prevention strategy in order to prevent the poor outcome in one patient. NP equals the reciprocal of ARR (if ARR is expressed as percentage, then NP=100% / ARR); its CI is reciprocals of the upper and lower limits of 95% CI: ARR.

NP = 100% / САР = 100% / 17.5% = 6.

This means that if 6 girls at risk for vulvovaginitis strictly follow our recommendations, then at least one of them will not develop vulvovaginitis within a year. It should be noted that for our sample size, CI for NP is 3 to 38 individuals.
Comparison of relapse rates in the group that was given original recommendations and the statistics on the prevalence of vulvovaginitis in the population confirmed the positive effect of the proposed prevention strategy. Relapses occurred in 17.4% of the girls form the group at risk for the pathology (Clopper–Pearson 95% CI was 8.6–31.4%). In the follow-up period, 6 girls developed clinical symptoms of nonspecific vulvovaginitis; the vaginal swabs obtained from 3 of those 6 girls revealed bacterial contamination. Those figures differed significantly (р < 0.001) from the population data; the latter suggest that on average, relapses of lower genital tract inflammation in this age group occur in 60% of cases [23, 24].

DISCUSSION

The obtained data are consistent with the results of another study demonstrating that, as a rule, vulvovaginitis is caused by nonspecific factors and that adequate hygiene practices have the best prevention effect against bacterial vulvovaginitis [25].
The importance of good feminine hygiene products and adequate intimate hygiene practices is emphasized in another study reporting that 25% of the respondents use vaginal douching, 29% use sprays, and 19%, topical antiseptics in order to prevent STD, which increases the risk of vaginal microbiota dysbiosis [26].
A cross-sectional study conducted in Slovakia has identified the most common intimate hygiene malpractices in female adolescents and young women between 15 and 22 years of age, including total hair removal in the intimate area (95%), bad hygiene before and after intercourse (38%), wearing a damp bathing suit instead of changing it to a dry one (58.06%), wearing unsuitable underwear. Younger respondents (15 to 19 years) and women with a lower educational status had worse hygiene habits that could be associated with unawareness of the related intimate health problems [27].
The analysis of the literature on the dysbiosis of vaginal microbiota at young age reveals no consensus on the predictors of this pathology.
Studies of vaginal microbiota covering its age-related aspects are scarce and do not often account for the stage of reproductive system development a participant is undergoing at the moment.
The role of polymorphisms and the expression of cytokine genes in driving the pathology is understudied.
There is a need for a comprehensive study of endogenous (vaginal microbiota, polymorphisms of immune response genes, somatic health) and exogenous factors (behavior) contributing to and driving vulvovaginal inflammation.

CONCLUSIONS

1. The proposed models for predicting genital inflammation account for Tanner stages of sexual development and can be used in girls between 2 and 17 years of age to decide on the treatment or prevention strategy. 2. This study provides the rationale conforming with the principles of evidence-based medicine for using prevention measures in the groups at risk for vulvovaginitis at young age. These measures allow reducing the relapse rate of bacterial vulvovaginitis threefold. 3. The proposed algorithm can be further improved using modern software and the personalized approach for the identification of groups at risk.

КОММЕНТАРИИ (0)